Vimta Labs Ltd. — Investor Relations & Filings
Vimta Labs Ltd. is a contract research and testing organization providing comprehensive scientific services across multiple sectors. The company specializes in analytical testing, clinical research, preclinical studies, and environmental monitoring. Its service portfolio includes pharmaceutical analysis, biopharmaceutical characterization, food safety testing, and diagnostic services. Vimta operates advanced laboratory facilities equipped to handle complex regulatory requirements, including compliance with global standards such as GLP, GCP, and ISO. The organization supports the life sciences, food, and electronics industries by offering specialized services like molecular biology, microbiology, and toxicology assessments. By integrating multi-disciplinary expertise, the company facilitates product development, quality control, and safety evaluations for a global clientele.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Dividend | 2021-05-14 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2021-05-12 | English | |
| Copy of Newspaper Publication | 2021-05-11 | English | |
| Board Meeting — Financial Results/Dividend | 2021-05-07 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2021-04-16 | English | |
| Price movement | 2021-04-14 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2021
15 filings
| |||||
| 43222170 | Dividend | 2021-05-14 | English | ||
| 43206672 | Analysts/Institutional Investor Meet/Con. Call Updates | 2021-05-12 | English | ||
| 43211212 | Copy of Newspaper Publication | 2021-05-11 | English | ||
| 44022722 | Board Meeting — Financial Results/Dividend | 2021-05-07 | English | ||
| 43232248 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2021-04-16 | English | ||
| 43220441 | Price movement | 2021-04-14 | English | ||
| 43235529 | Disclosure under SEBI Takeover Regulations | 2021-04-06 | English | ||
| 43229327 | Trading Window | 2021-03-31 | English | ||
| 43240629 | Appointment | 2021-02-22 | English | ||
| 43243451 | Resignation | 2021-01-28 | English | ||
| 43243745 | Analysts/Institutional Investor Meet/Con. Call Updates | 2021-01-28 | English | ||
| 43265635 | Copy of Newspaper Publication | 2021-01-23 | English | ||
| 43268278 | Limited Review Report | 2021-01-23 | English | ||
| 43268312 | Financial Results Updates | 2021-01-23 | English | ||
| 43268631 | Financial Result Updates | 2021-01-23 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Vimta Labs Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61730/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61730 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61730 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61730 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61730}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Vimta Labs Ltd. (id: 61730)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.